Biology Reference
In-Depth Information
138. Liu Z, Yang F, Robotham JM, Tang H (2009) Critical role of cyclophilin A and its prolyl-
peptidyl isomerase activity in the structure and function of the hepatitis C virus replication
complex. J Virol 83:6554-6565
139. Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T (2010)
Evidence for the cure of HIV infection by CCR5{Delta}32/{Delta}32 stem cell transplanta-
tion. Blood 117(10):2791-2799
140. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN,
Clark R, Guzman D, Zolopa A et al (2003) High levels of adherence do not prevent accumu-
lation of HIV drug resistance mutations. AIDS 17:1925-1932
141. Menendez-Arias L (2010) Molecular basis of human immunodeficiency virus drug resis-
tance: an update. Antiviral Res 85:210-231
142. Lapidot T (2001) Mechanism of human stem cell migration and repopulation of NOD/SCID
and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci
938:83-95
143. Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H (2008) Cyclophilin A is
an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine
resistance in vitro. J Virol 82:5269-5278
144. Gaspar HB, Thrasher AJ (2005) Gene therapy for severe combined immunodeficiencies.
Expert Opin Biol Ther 5:1175-1182
145. Parkin NT, Chamorro M, Varmus HE (1992) Human immunodeficiency virus type 1 gag-pol
frameshifting is dependent on downstream mRNA secondary structure: demonstration by
expression in vivo. J Virol 66:5147-5151
146. Goff SP (2008) Knockdown screens to knockout HIV-1. Cell 135:417-420
147. Eekels JJM, Berkhout B (2011) Toward a durable treatment of HIV-1 infection using RNA
interference. In: Grimm D (ed) Cellular RNA interference mechanisms, vol 102. Elsevier,
London, pp 141-163
148. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda
DJ, Espeseth AS, Konig R et al (2009) Host cell factors in HIV replication: meta-analysis of
genome-wide studies. PLoS Pathog 5:e1000437
149. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie
LA, Hess S et al (2010) Genome-wide RNAi screen identifies human host factors crucial for
influenza virus replication. Nature 463:818-822
150. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne
DM, Ortigoza MB, Liang Y et al (2010) Human host factors required for influenza virus
replication. Nature 463:813-817
151. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, Liang TJ, Elledge SJ (2009) A genome-wide genetic
screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci USA
106:16410-16415
152. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, Rodgers MA, Ramirez
JL, Dimopoulos G, Yang PL, Pearson JL et al (2009) Discovery of insect and human dengue
virus host factors. Nature 458:1047-1050
153. van den Berg CH, Smit C, Bakker M, Geskus RB, Berkhout B, Jurriaans S, Coutinho RA,
Wolthers KC, Prins M (2007) Major decline of hepatitis C virus incidence rate over two
decades in a cohort of drug users. Eur J Epidemiol 22:183-193
154. Wheatley AK, Kramski M, Alexander MR, Toe JG, Center RJ, Purcell DF (2011)
Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular
immunity from an HIV-1 Env DNA vaccine. PLoS One 6:e18225
155. Liu Z, Robida JM, Chinnaswamy S, Yi G, Robotham JM, Nelson HB, Irsigler A, Kao CC,
Tang H (2009) Mutations in the hepatitis C virus polymerase that increase RNA binding can
confer resistance to cyclosporine A. Hepatology 50(1):25-33
156. Boudreau RL, Monteys AM, Davidson BL (2008) Minimizing variables among hairpin-
based RNAi vectors reveals the potency of shRNAs. RNA 14:1834-1844
157. Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA-target recogni-
tion. PLoS Biol 3:e85
Search WWH ::
Custom Search